Soluble guanylyl cyclase expression and signaling in different types of liver fibrosis
Ksenia Brusilovskaya(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Stefan Günther Kauschke, Benedikt Hofer(Austrian Academy of Sciences), Martha Seif, Philipp Schwabl(Austrian Academy of Sciences), Larissa Pfisterer(Boehringer Ingelheim (Germany)), Kerstin Zinober(Medical University of Vienna), Philipp Königshofer(Medical University of Vienna)
Cited by 0
Related Papers
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
|Journal of Hepatology|2021|309
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
|Journal of Hepatology|2024|239
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality
|Journal of Hepatology|2020|202
Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
|Clinical Gastroenterology and Hepatology|2022|130
An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis
|Nature Protocols|2015|119